Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): A patient's perspective

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Kronenberg, Linda M ^a,b   Slager Visscher, Karin ^c   Goossens, Peter J J ^d,e,f   van den Brink, Wim ^g   van Achterberg, Theo ^f,h,i  

^a Department of residency training MANP mental health ^*  (Netherlands)

^b Advanced Nurse Practitioner Dual Diagnosis Department Dimence   (Netherlands)

^c Functie Assertive Community Treatment   (Netherlands)

^d SAXION UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^e SCBS   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adults; Attention deficit hyperactivity disorder; Autism spectrum disorder; Everyday life consequences; Substance use disorders

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE;

ADDICTION; ADULT; AGITATION; AMBIGUITY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DESCRIPTIVE RESEARCH; EMOTION; FEMALE; HUMAN; IMPULSIVENESS; INTERVIEW; MALE; MELANCHOLIA; PATIENT ATTITUDE; PHENOMENOLOGY; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEXUAL BEHAVIOR; SOCIAL INTERACTION; SUBSTANCE ABUSE; SUBSTANCE USE; THINKING; TREATMENT PLANNING; ADOLESCENT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION; MIDDLE AGED; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908149594     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0264-1     Document Type: Article

References (30)

1. Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry 2012, 25:194-200. 10.1097/YCO.0b013e328351a3e0, 22395768.
2. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. The journal of the American Medical Association 1990, 264:2511-2518. 10.1001/jama.1990.03450190043026.
3. Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Abuse 2004, 30:4:749-764. 10.1081/ADA-200037538.
4. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012, 37:11-24. 10.1016/j.addbeh.2011.09.010, 21981788.
5. Wilens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry 2011, 24:280-285. 10.1097/YCO.0b013e328345c956, 21483267.
6. Van Emmerik-Van OK, Van de Glind G, Van den Brink B, Smit F, Crunelle CL, Swetsa M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012, 122:11-19. 10.1016/j.drugalcdep.2011.12.007.
7. Singh SKB, Hellemans H, Dom G. Autism spectrum disorder and substance use disorder: an unknown comorbidity? [Article in Dutch: Autismespectrumstoornis en verslaving: een onbekende comorbiditeit?]. Tijdschr Psychiatr 2012, 54:10:893-897.
8. Hofvander B, Delorme R, Chaste P, Agneta Nydén A, Wentz E, Stahlberg O, Herbrecht E, Stopin A, Anckarsäter H, Gillberg C, Rastam M, Leboyer M. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry 2009, 9:35. 10.1186/1471-244X-9-35, 19515234.
9. Lugnegard T, Hallerback MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil 2011, 32:1910-1917. 10.1016/j.ridd.2011.03.025, 21515028.
10. Sizoo B, Van den Brink W, Koeter M, Gorissen van Eenigee M, Van Wijngaarden-Cremers P, Van der Gaag RJ. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug Alcohol Depend 2010, 107:44-50. 10.1016/j.drugalcdep.2009.09.003, 19786328.
11. Kronenberg LM, Goossens PJJ, Van Etten M, Van Achterberg T, Van den Brink W: Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).Perspect Psychiatr Care 2014. Epub ahead of print..
12. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001, 52:4:469-476. 10.1176/appi.ps.52.4.469.
13. Edward K, Robins A. Dual diagnosis, as described by those who experience the disorder: using the internet as a source of data. Int J Ment Health Nurs 2012, 21:550-559. 10.1111/j.1447-0349.2012.00833.x, 22830579.
14. Saitz R, Larson MJ, LaBelle C, Richardson J, Samet JH. The case for chronic disease management for addiction. Journal of Addiction Medicine 2008, 2:2:55-65. 10.1097/ADM.0b013e318166af74.
15. Colaizzi P. Psychological research as the phenomenologist views it. Existential phenomenological alternatives for psychology 1978, 48-71. Oxford University Press, New York, Valle R, King M.
16. Barkley RA. The role of executive function and self-regulation. J Clin Psychiatry 2010, 71:7:e17. 10.4088/JCP.9066tx1c.
17. Chanraud S, Martelli C, Delain F, Kostogianni N, Douaud G, Aubin HJ, Reynaud M, Martinot JL. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 2007, 32:429-438. 10.1038/sj.npp.1301219, 17047671.
18. Cohen LJ, Nesci C, Steinfeld M, Haeri S, Galynker I. Investigating the relationship between sexual and chemical addictions by comparing executive function in pedophiles, opiate addicts and healthy controls. J Psychiatr Pract 2010, 16:6:405-412. 10.1097/01.pra.0000390759.04581.7c.
19. Kushner MG, Mueser KT. Psychiatric co-morbidity with alcohol use disorders. Eight Special Report to the U.S. Congress on Alcohol and Health 1993, 37-59. U.S. Department of Health and Human Services, Rockville, MD, NIH Publication, No. 94-3699.
20. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 2005, 81:319-330. 10.1016/j.pbb.2005.02.017, 15925403.
21. Oscar-Berman M, Shagrin B, Evert DL, Epstein C. Impairments of brain and behavior: the neurological effects of alcohol. Alcohol Health Res World 1997, 21:1:65-75.
22. Weinborn M, Woods SP, O'Toole S, Kellogg EJ, Moyle J. Prospective memory in substance abusers at treatment entry: associations with education, neuropsychological functioning, and everyday memory lapses. Arch Clin Neuropsychol 2011, 26:746-755. 10.1093/arclin/acr071, 21903701.
23. Altgassen M, Koban N, Kliegel M. Do adults with autism spectrum disorders compensate in naturalistic prospective memory tasks?. J Autism Dev Disord 2012, 42:2141-2151. 10.1007/s10803-012-1466-3, 22350339.
24. Rosenthal M, Wallace GL, Lawson R, Wills MC, Yerys BE, Kenworthy L. Impairments in real-world executive function increase from childhood to adolescence in autism spectrum disorders. Neuropsychology 2013, 27:1:13-18. 10.1037/a0031299.
25. Van Amsterdam J, Van den Brink W. Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol 2013, 27:11:987-997. 10.1177/0269881113495320.
26. Polit DF, Beck CT. Nursing research: principles and methods 2004, Lippincott Williams & Wilkins, Philadelphia.
27. Saldana J. The coding manual for qualitative researchers 2009, Sage, London.
28. Barkley RA. Executive functions: what they are, how they work, and why they evolved 2012, The Guilford Press, New York.
29. Van Emmerik-Van Oortmerssen K, Vedel E, Koeter MW, De Bruijn K, Dekker JJM, Van den Brink W, Schoevers RA. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry 2013, 13:132. 10.1186/1471-244X-13-132, 23663651.
30. Wilens TE, Adamson J, Sgambati S, Whitley J, Santry A, Monuteaux MC, Biederman J. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? results from a controlled family study of ADHD. Am J Addict 2007, 16:14-23. 10.1080/10550490601082742, 17453603.